BUSINESS Lantern Pharma Announces Successful Outcome of FDA Type C Meeting Request for HARMONICTM Phase 2 Trial of LP-300 in Never-Smokers with NSCLC Tuesday, May 19, 2026 Advertisement Read Original Article → Related Dispatches [EU] · Jul 4 Ethereum News: EthLabs Launches During Leadership Reset as AlphaPepe Builds the AI DEX Presale Case [EU] · Jul 4 Bittensor Price Prediction Stalls at $213 While Pepeto Presale Secures $10.3 Million Before Listing [EU] · Jul 4 5 Best Cryptos To Invest In Before Retail FOMO Returns as Bitcoin Reclaims Its Strongest Level in Two Weeks